Clinical activity of single agent pertuzumab (rhuMab 2C4), a HER dimerization inhibitor, in advanced ovarian cancer (OC): Potential predictive relationship with tumor HER2 activation status Meeting Abstract
| Authors: | Gordon, M. S.; Matel, D.; Aghajanian, C.; Matulonis, U.; Brewer, M.; Fleming, G.; Hainsworth, J.; Garcia, A. A.; Pegram, M.; Karlan, B. |
| Abstract Title: | Clinical activity of single agent pertuzumab (rhuMab 2C4), a HER dimerization inhibitor, in advanced ovarian cancer (OC): Potential predictive relationship with tumor HER2 activation status |
| Meeting Title: | 13th European Cancer Conference (ECCO 13) |
| Journal Title: | EJC Supplements |
| Volume: | 3 |
| Issue: | 2 |
| Meeting Dates: | 2005 Oct 30-Nov 3 |
| Meeting Location: | Paris, France |
| ISSN: | 1359-6349 |
| Publisher: | Pergamon-Elsevier Science Ltd |
| Date Published: | 2005-10-01 |
| Start Page: | 259 |
| End Page: | 260 |
| Language: | English |
| ACCESSION: | WOS:000247564801059 |
| PROVIDER: | wos |
| DOI: | 10.1016/S1359-6349(05)81198-X |
| Notes: | --- - Meeting Abstract: 903 - S - "Source: Wos" |
